These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 1357564)
1. Serotonergic pathology is not widespread in Alzheimer patients without prominent aggressive symptoms. Procter AW; Francis PT; Stratmann GC; Bowen DM Neurochem Res; 1992 Sep; 17(9):917-22. PubMed ID: 1357564 [TBL] [Abstract][Full Text] [Related]
2. Neurochemical characteristics of early and late onset types of Alzheimer's disease. Rossor MN; Iversen LL; Reynolds GP; Mountjoy CQ; Roth M Br Med J (Clin Res Ed); 1984 Mar; 288(6422):961-4. PubMed ID: 6142750 [TBL] [Abstract][Full Text] [Related]
3. Possible neurotransmitter basis of behavioral changes in Alzheimer's disease. Palmer AM; Stratmann GC; Procter AW; Bowen DM Ann Neurol; 1988 Jun; 23(6):616-20. PubMed ID: 2457353 [TBL] [Abstract][Full Text] [Related]
5. A post-mortem study of noradrenergic, serotonergic and GABAergic neurons in Alzheimer's disease. Reinikainen KJ; Paljärvi L; Huuskonen M; Soininen H; Laakso M; Riekkinen PJ J Neurol Sci; 1988 Mar; 84(1):101-16. PubMed ID: 2452858 [TBL] [Abstract][Full Text] [Related]
6. Gamma-aminobutyric acid concentration in brain tissue at two stages of Alzheimer's disease. Lowe SL; Francis PT; Procter AW; Palmer AM; Davison AN; Bowen DM Brain; 1988 Aug; 111 ( Pt 4)():785-99. PubMed ID: 3401683 [TBL] [Abstract][Full Text] [Related]
7. Human striatum: chemoarchitecture of the caudate nucleus, putamen and ventral striatum in health and Alzheimer's disease. Selden N; Geula C; Hersh L; Mesulam MM Neuroscience; 1994 Jun; 60(3):621-36. PubMed ID: 7523983 [TBL] [Abstract][Full Text] [Related]
8. Postmortem studies of peptides in Alzheimer's disease and Huntington's disease. Rossor M; Emson P; Dawbarn D; Dockray G; Mountjoy C; Roth M Res Publ Assoc Res Nerv Ment Dis; 1986; 64():259-77. PubMed ID: 2425405 [No Abstract] [Full Text] [Related]
9. Galanin immunoreactivity is increased in the nucleus basalis of Meynert in Alzheimer's disease. Beal MF; MacGarvey U; Swartz KJ Ann Neurol; 1990 Aug; 28(2):157-61. PubMed ID: 1699471 [TBL] [Abstract][Full Text] [Related]
10. Neurotransmitters of the cerebral cortex in senile dementia of Alzheimer type. Rossor MN; Emson PC; Mountjoy CQ; Roth M; Iversen LL Exp Brain Res; 1982; Suppl 5():153-7. PubMed ID: 6129994 [No Abstract] [Full Text] [Related]
11. Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of later life. Bowen DM; Najlerahim A; Procter AW; Francis PT; Murphy E Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9504-8. PubMed ID: 2574463 [TBL] [Abstract][Full Text] [Related]
12. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa. Davies P; Katzman R; Terry RD Nature; 1980 Nov; 288(5788):279-80. PubMed ID: 6107862 [TBL] [Abstract][Full Text] [Related]